Rotate signs outfitting deal with Denmark's women's football team
Founded in 2018 by designers Jeanette Madsen and Thora Valdimars, Rotate is known for its bold silhouettes, structured denim, and playful femininity. For the national team, the brand created a coordinated wardrobe featuring sky-blue button-up shirts with floral embroidery, matching shorts, signature denim pieces, as well as polos and caps.
The collaboration marks Rotate's second with the Danish Football Association (DBU). In April 2023, the label partnered with the team's kit supplier, Hummel, on a limited-edition capsule that included a co-branded jersey and matching sportswear items designed by Rotate.
'We're proud to support and help raise the visibility of women's football—both in Denmark and internationally,' the brand said in a statement.
Based in Copenhagen, Rotate is a mainstay at Copenhagen Fashion Week and operates a flagship store in the city. The brand reported €16 million in global sales in 2023.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
3 days ago
- Euronews
How does doping affect athletes' health?
This weekend promises to be an exciting one for sports fans. The World Aquatics Championships in Singapore begin their third weekend of competition, while the prestigious Tour de France concludes on Sunday, marking the end of one of cycling's greatest events. To cap off the weekend, the UEFA Women's EURO 2025 final takes place on Sunday evening in Basel, Switzerland, with world champions Spain facing European champions England. These three major events comprise different sports in different parts of the world, but they are united by one common aspect: anti-doping. Athletes participating in these events are closely monitored to ensure that these competitions remain free from banned substances listed on the World Anti-Doping Agency (WADA) Prohibited List. In the last three episodes of Euronews Next's podcast Euronews Tech Talks, we've explored how complex it is for anti-doping authorities to detect doping and the reasons why some professional athletes resort to it. But what exactly are the physical health risks associated with performance-enhancing drugs? Some preliminary remarks Before exploring the health risks associated with some of the most commonly used doping substances, there are some important points to make. To be included on the WADA Prohibited List, drugs and practices must fulfil at least two out of three criteria: they have the potential to enhance or do enhance sport performance; they represent an actual or potential health risk to the athlete; they violate the spirit of sport. This means a substance may only be performance-enhancing and violate the spirit of sport, or it may pose no actual health risk but a possible one. 2. Doping is a tricky research field In episode 50, Francesco Botrè, Director of the WADA-accredited anti-doping laboratory in Rome, highlighted that researching doping is complicated because studies must respect ethical and health safety criteria. For example, researchers cannot administer high doses of certain banned substances to study participants due to potential health risks. 3. Research on doping is relatively recent As noted in episode 51 by Dominic Sagoe, Professor of Psychology at the University of Bergen, research on doping is relatively recent, and the substances athletes use are also new, making it difficult to assess their long-term effects. 4. There is a health dilemma As often in health-related subjects, it is hard to define with certainty a cause-and-effect relationship between the use of a substance and a body reaction, as many aspects, such as genetics and environmental contexts, are often overlooked. 5. Difficult to identify Athletes using performance-enhancing drugs might take more than one banned substance, making it difficult to isolate the health effects of each substance. Anabolic steroids Anabolic steroids are among the doping substances whose health effects are most well-documented. They are used in sports like sprint competitions or weight lifting because they speed up protein synthesis in muscles, leading to increased muscle mass and strength. A famous case of steroid use involves tennis player Jannik Sinner, who won Wimbledon this year. The Italian athlete tested positive for steroids in March 2024 and received a three-month ban by WADA. These products can cause major physical side effects. 'Since the heart is also a muscle and steroids lead to muscle growth, the heart itself could also grow,' Astrid Kristine Bjørnebekk, group leader of the Anabolic Androgenic Steroid Research Group at the Oslo University Hospital, told Euronews Health. 'So it [the heart] increases in size, the ventricular walls get thicker and stiffer, which will affect the heart's ability to pump blood to the rest of the body and over time, this can lead to heart failure'. Some studies have also suggested that these heart problems may persist in the long term. Bjørnebekk explained that anabolic steroids disrupt hormone production, and research has also found reduced brain volume in the cerebral cortex among users, though scientists are still working to understand what these changes mean. Erythropoietin (EPO) and blood doping Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells, enhancing endurance. It is mostly used in competitions such as cycling or marathon running. Similarly, blood doping involves removing blood and re-transfusing it after the body has replaced the lost blood cells. This increases the total red blood cell count, improving the athlete's capacity to perform in the short term. The most well-known athlete to have used these substances is the United States' cyclist Lance Armstrong, who admitted using banned substances in an interview with Oprah Winfrey in 2013. Overall, both blood doping and EPO are associated with risks of infections and major cardiovascular problems like blood clots, strokes and heart attacks. However, this verified connection should be approached with caution and analysed on a case-by-case basis. For instance, in the 1990s and 2000s, media and experts suggested that over 15 Belgian and Dutch cyclists had died from heart attacks in the late 1980s due to EPO use. However, later studies found no clear evidence to support this claim, highlighting that the cause-and-effect relationship is more nuanced. Unlike steroids, research on the long-term effects of EPO and blood doping is somewhat more limited. Beta Blockers Probably less known than other performance-enhancing drugs, beta blockers are medications normally used for heart conditions. They are banned in specific sports like archery and shooting because they help athletes perform more calmly by keeping their heart rate low and reducing tension in their bodies. One of the most famous athletes who tested positive for beta blockers was North Korean shooter Kim Jong-su, who tested positive during the 2008 Beijing Olympics. Common side effects include fatigue, dizziness, nausea, constipation, and erectile dysfunction. As far as long-term issues are concerned, some studies have associated chronic use of beta blockers with an increased risk of Parkinson's disease. However, there is little research focused specifically on beta blockers use in sports.
France 24
3 days ago
- France 24
Zelensky seeks EU support while Ukraine struggles with corruption
03:26 24/07/2025 EU-China ties hit 'inflection point' and calls climate chage 'a priority' Europe 24/07/2025 EU says China's links with Russia now 'determining factor' in ties Europe 24/07/2025 EU tariffs on chinese EVs strain trade and diplomatic ties with Beijing Economy 24/07/2025 Spain beats Germany in Women's Euro 2025 and will play England on Sunday Europe 24/07/2025 War in Ukraine : Russia agrees prisoner swap but no deal on ceaserfire Europe 20/07/2025 Zelensky offers to hold new talks for ceasefire Europe 19/07/2025 EU launches new sanctions against Russia for more effective oil price cap Europe 17/07/2025 EU proposes 'most ambitious ever' budget of two trillion euros Europe
Fashion Network
4 days ago
- Fashion Network
Fédération unveils bumper Paris ready-to-wear season, with nine designer debuts
France's Fédération de la Haute Couture et de la Mode on Thursday unveiled a bumper Paris ready-to-wear catwalk season, bristling with nine designer debuts and key houses, in the most anticipated Paris Fashion Week this century. See catwalk The French's capital's two most famous fashion houses, Chanel and Christian Dior, will both feature women's ready-to-wear show debuts by their freshly appointed creative directors – Matthieu Blazy and Jonathan Anderson, even if the latter has already had his Dior menswear baptism with a men's show in June. A further seven major labels will stage debut shows by new creative talent. They are the hyper-experienced Mark Howard Thomas at Carven; Michael Rider at Celine; Lazaro Hernandez and Jack McCollough at Loewe; Duran Lantink at Jean-Paul Gaultier; Glenn Martens at Maison Margiela; Miguel Castro Freitas at Mugler and the acclaimed Italian master Pier Paolo Piccioli at Balenciaga. Though, it should be noted, Rider did show a special spring 2026 Celine co-ed collection on the eve of Paris couture season at the start of July, while Martens presented his first couture collection for Margiela three days later. In effect, these first six houses and a further four – Agnès B, Lanvin, Thom Browne and Vetements - are all returning to the Paris ready-to-wear catwalk week after a hiatus ranging from one season to over five years in the case of Gaultier, since founder Jean-Paul stepped down in 2020. All told, there will be a hefty grand total of 76 physical catwalk shows, and 36 by-appointment presentations in this fall's nine-day Paris Fashion Week, which runs from Monday, September 29 to Tuesday, October 7. The clothes displayed will be for spring/summer 2026. See catwalk The FHCM, French fashion's governing body, has also welcomed on to the official calendar two very happening new houses. Matières Fécales, or Fecal Matters, founded by Hannah Rose and Steven Raj, who are known for their extremist glamour and post-human aesthetic. They will show after Louis Vuitton on Tuesday, September 30. Meryll Rogge, the highly popular winner of the latest ANDAM fashion prize, will climax the busy season with a 6 p.m. show on October 7. Rogge has also just been named the new creative director of Jil Sander, which shows in Milan. While, hyper-acclaimed Alaia alumna Julie Kegels will stage a must-see show on the opening Monday. Entrance onto the official Federation calendar is notoriously difficult to achieve, given French insistence on maintaining a uniquely high level of creativity, quality, production and staging in Paris. Which makes it a significant achievement that a further two houses have been approved to stage presentations on the official calendar: eco-conscious label Façon Jacmin from sisters Alexandra and Segolène Jacmin and Ganni, the hipster Danish label from husband-and-wife team Nicklas and Ditte Reffstrup. Torishéju, by the talented British designer of Nigerian-Brazilian origin Torishéju Dumi, will stage an off-calendar presentation. This bumper Fashion Week – with shows running from 10 a.m. to 8 p.m. daily - will also feature global bold face labels like Louis Vuitton, Schiaparelli, Balenciaga and Hermès, along with indie houses led by hot talent, like Courrèges, Dries Van Noten or Tom Ford and a triumvirate of legendary Japanese houses - Yohji Yamamoto, Comme des Garçons and Issey Miyake. See catwalk Plus, there will be a series of highly talented female designer who have of late staged their most evolved collections in Paris for their own brands or as guns for hire – Victoria Beckham, Gabriela Hearst, Stella McCartney, The Row and Givenchy. Fasten your seat belts for the kickiest season in decades.
